Malaria is common in the African continent, and continues to claim many lives daily, leading scientists to explore various ways to rid the continent of the menace
Africa is close to winning its war against Malaria as a new anti-malarial vaccine is soon to hit pharmaceutical stores.
Health authorities in Burkina Faso have given the go-ahead to test the new malaria vaccine on young children in a bid to save millions.
Ghana and Nigeria have already approved the R21 vaccine.
You Might Like This:Â Godwin Emefiele Pleads Not Guilty To Criminal Charge
Malaria is the leading cause of infant mortality in Burkina Faso.
Health Minister, Robert Kargougou, says this new vaccine will be an extremely important tool in the effort to eliminate the disease.
Researchers say trials involving 5,000 children have been successful.
Children aged between five months and 36 months will have access to the R21 vaccine, and each dose is likely to cost a couple of US dollars.
The Serum Institute of India can produce two million doses a year, and a factory is also to be built in Ghana which has already approved use of the vaccine along with Nigeria.
